Gateway Investment Advisers LLC Purchases 113 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Gateway Investment Advisers LLC lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 925 shares of the biopharmaceutical company’s stock after buying an additional 113 shares during the period. […]
Gateway Investment Advisers LLC lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 925 shares of the biopharmaceutical company’s stock after buying an additional 113 shares during the period. […]
